Impact of the Atlas 2030 Pediatric Exoskeleton on Gait Functionality and Quality of Life in Children With Cerebral Palsy or Related Conditions

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

July 31, 2023

Conditions
Cerebral Palsy Infantile
Interventions
DEVICE

ATLAS 2030 Exoskeleton

They underwent intensive training with 4 weekly sessions during 6 weeks with the ATLAS 2030 exoskeleton, a wearable device that provides gait assistance through eight degrees of freedom, four for each leg, including hip, knee, and ankle rotations. During training sessions, participants were fitted with the exoskeleton and performed 25 minutes of automatic forward walking, 15 minutes of active forward walking, 15 minutes of automatic forward walking, 5 minutes of automatic backward walking, 5 minutes of active backward walking, and exoskeleton removal. During the walk, therapeutic activities based on therapeutic objectives were carried out according to the participants' abilities.

Trial Locations (1)

20500

Ospitalarioak Fundazioa Euskadi, Arrasate / Mondragón

All Listed Sponsors
collaborator

Hospital Aita Menni

UNKNOWN

collaborator

ASPACE Gipuzkoa

UNKNOWN

lead

FIDMAG Germanes Hospitalàries

OTHER

NCT07066956 - Impact of the Atlas 2030 Pediatric Exoskeleton on Gait Functionality and Quality of Life in Children With Cerebral Palsy or Related Conditions | Biotech Hunter | Biotech Hunter